2016 FE 0097 (Q3336195)
Jump to navigation
Jump to search
Project Q3336195 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | 2016 FE 0097 |
Project Q3336195 in Germany |
Statements
520,778.38 Euro
0 references
650,972.97 Euro
0 references
80.0 percent
0 references
22 November 2016
0 references
21 November 2019
0 references
HAPILA GmbH
0 references
07552
0 references
GMP-BTZ043 - Erforschung neuer Syntheseschritte und Entwicklung eines darauf basierenden Herstellungsverfahrens nach den international geltenden Vorschriften der Good Manufacturing Practice (GMP) für das tuberkulostatische Benzothiazinon BTZ043 (German)
0 references
GMP-BTZ043 — Research on new synthesis steps and development of a manufacturing process based on this in accordance with the internationally applicable Good Manufacturing Practice (GMP) for tuberculostatic benzothiazinone BTZ043 (English)
25 October 2021
0 references
GMP-BTZ043 — Recherche de nouvelles étapes de synthèse et mise au point d’un procédé de fabrication basé sur ces dernières, conformément aux règles internationales de bonnes pratiques de fabrication (BPF) pour la benzothiazinone tuberculostatique BTZ043 (French)
7 December 2021
0 references
GMP-BTZ043 — Onderzoek naar nieuwe synthesestappen en ontwikkeling van een productieproces op basis hiervan in overeenstemming met de internationaal toepasselijke Good Manufacturing Practice (GMP) voor tuberculostatische benzothiazinone BTZ043 (Dutch)
19 December 2021
0 references
GMP-BTZ043 — Ricerca su nuove fasi di sintesi e sviluppo di un processo di fabbricazione basato su questo in conformità con le buone pratiche di fabbricazione (GMP) applicabili a livello internazionale per il benzothiazinone tubercolostatico BTZ043 (Italian)
19 January 2022
0 references
Identifiers
DE_TEMPORARY_38840
0 references